Yamashita Health Care Holdings,Inc.
【Yamashita Healthcare】Revisions to FY2026 Full-Year Earnings Forecast | Sales of 64,149 million yen
Yamashita Healthcare's consolidated earnings forecast for FY2026 project net sales of 64,149 million yen (down 3,497 million yen, 5.2% decrease from previous estimate), and net income attributable to owners of the parent of 648 million yen (up 294 million yen, 83.1% increase), significantly exceeding previous expectations.
Key Figures
- Net Sales: 64,149 million yen (△5.2%)
- Net Income Attributable to Owners of the Parent: 648 million yen (83.1% increase)
- Operating Income: 737 million yen (24.9% increase)
AI要約
Performance Overview
Yamashita Healthcare's consolidated earnings forecast for FY2026 indicates net sales of 64,149 million yen, a decrease of 3,497 million yen from the previous estimate. However, net income attributable to owners of the parent significantly exceeded expectations at 648 million yen, marking an increase of 83.1%. Ordinary income also surpassed expectations at 877 million yen, and operating income rose by 24.9% to 737 million yen. These results are primarily due to the reversal of allowance for doubtful accounts related to Gemic Co., Ltd., which went bankrupt in 2023, and the tax effect of certain deductible expenses.
Future Outlook and Impact
The upward revision of actual results is mainly due to the reversal of uncollectible accounts and the tax effects related to Gemic Co., Ltd.'s bankruptcy termination. These factors are likely to continue influencing future business activities. Although sales fell below expectations, the substantial increase in net income is positive for investors. Going forward, it will be important to monitor performance excluding these special factors.
Yamashita Healthcare Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
